What It’s All About
Colossal is a startup aiming to revive extinct species using advanced genetic editing. The CEO, Ben Lamm, emphasizes that the company is not creating a real-life Jurassic Park but rather focusing on ethical de-extinction. With the goal of restoring species like the woolly mammoth, dodo bird, and Tasmanian tiger, Colossal has gained substantial investor support, raising hundreds of millions and reaching a valuation of $10.2 billion.
Key Details
- Colossal plans to produce woolly mammoth hybrid calves by 2028 for reintroduction to the Arctic.
- The company is also working on releasing Tasmanian tiger joeys back into their natural habitat.
- A recent project involved creating a gene-edited “woolly mouse” to validate mammoth research.
- Lamm believes combining AI and synthetic biology will lead to significant advancements, including cures for diseases and environmental solutions.
Why It Matters
The work of Colossal could reshape conservation efforts and address the impact of human activities on biodiversity. By reviving extinct species, the company aims to restore ecosystems and foster a better understanding of genetic technologies. Lamm’s vision extends beyond de-extinction, touching on human longevity and environmental sustainability. This ambitious approach could inspire future innovations in both science and ethics, challenging society to rethink its relationship with nature.
